Phase I Trial of Pacritinib in Combination With Venetoclax and Azacitidine for the Treatment of Accelerated and Blast Phase Myeloproliferative Neoplasms

NCT07679334 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Myeloproliferative Neoplasm

Interventions

DRUG: Pacritinib
DRUG: Venetoclax
DRUG: Azacitidine
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Computed Tomography
PROCEDURE: Bone Marrow Aspiration

Sponsor

Roswell Park Cancer Institute